XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Tables)
 6 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of stock-based compensation expense
                
   Three Months
Ended December 31,		   Six Months
Ended December 31,		 
   2022   2021   2022   2021 
Cost of Goods Sold  $9,556   $28,415   $15,854   $56,830 
Research and Development   50,302    50,310    81,058    93,799 
Selling, General and Administrative   184,928    251,726    222,864    339,893 
Stock Based Compensation Expense  $244,786   $330,451   $319,776   $490,522 
Schedule of stock option activity
                       
      Options Outstanding  
      Number of
Shares		       Weighted Average
Exercise Price		       Weighted Average
Contractual Life		  
Outstanding at June 30, 2022     904,626     $ 4.00       7.08 years  
Exercised     –       –       –  
Granted     105,001       5.97       –  
Cancelled     (666 )     3.90       –  
Outstanding at December 31, 2022     1,008,961     $ 4.21       6.86 years  
Schedule of stock options outstanding by exercise price range
                                           
Range of
Exercise Prices		     Number of
Shares		     Weighted-
Average
Remaining
Contractual Life
(years)		     Weighted-
Average
Exercise Price		     Exercisable
Number of
Shares		     Exercisable
Weighted-
Average
Exercise Price		  
$ 1.44       20,000       3.24     $ 1.44       20,000     $ 1.44  
$ 1.50       26,666       3.47     $ 1.50       26,666     $ 1.50  
$ 1.65       5,000       5.25     $ 1.65       5,000     $ 1.65  
$ 2.10       33,333       5.59     $ 2.10       33,333     $ 2.10  
$ 2.19       209,996       4.16     $ 2.19       209,996     $ 2.19  
$ 2.55       2,000       0.01     $ 2.55       2,000     $ 2.55  
$ 2.70       12,000       1.44     $ 2.70       12,000     $ 2.70  
$ 3.75       15,000       7.22     $ 3.75       10,000     $ 3.75  
$ 3.90       146,325       6.45     $ 3.90       146,325     $ 3.90  
$ 4.20       23,332       7.88     $ 4.20       23,332     $ 4.20  
$ 4.26       33,333       6.70     $ 4.26       33,333     $ 4.26  
$ 4.35       1,666       8.19     $ 4.35       1,666     $ 4.35  
$ 4.50       23,332       6.94     $ 4.50       23,332     $ 4.50  
$ 5.04       179,997       8.43     $ 5.04       179,997     $ 5.04  
$ 5.61       10,000       9.36     $ 5.61       –     $ –  
$ 5.85       75,003       9.01     $ 5.85       –     $ –  
$ 6.00       33,330       8.32     $ 6.00       10,000     $ 6.00  
$ 6.26       29,998       9.88     $ 6.26       29,998     $ 6.26  
$ 6.27       81,986       9.11     $ 6.27       –     $ –  
$ 6.78       46,664       8.88     $ 6.78       35,553     $ 6.78  
$ 1.44–6.78       1,008,961       6.86     $ 4.21       802,531     $ 3.74  

 

The aggregate intrinsic value of the Company’s in-the-money outstanding and exercisable options as of December 31, 2022 was $1,546,353 and $1,537,253, respectively.